GLP-1 weight loss drugs

Telehealth company Hims & Hers Health has announced an AI-native weight loss care platform, building artificial intelligence into how patients receive weight loss treatment and support. The launch positions the company to compete more aggressively in the fast-growing market for weight loss care, where demand for GLP-1 drugs and digital health services has surged. Investors and industry watchers are watching how the move affects the company's growth prospects.